A Nanaimo teenager is among those losing access to support they say has changed their life. The B.C. Centre for Long COVID reduced treatment options after changes to MSP came into force November 1.
C
Read full storyCbc
Original source
Trending
Cold front brings cooler weather, breezy winds to DallasCentury-old barn rolls down Route 519 to new Ross Farm homeAAA Urges Caution as Deer Collision Risk Rises Across PennsylvaniaN.J. embraced AI. Flock cameras, deepfakes and Big Tech distrust have leaders wrestling with limits.Hubble Space Telescope is falling to Earth – should NASA save it?More than half of trucks inspected during North Texas operations were taken off road, agency saysThriller: Aruna risks everything to protect her baby niece from powerful men determined to kill herA drone attacked me on Salisbury Plain so I blew it to bits with a shotgunCold front brings cooler weather, breezy winds to DallasCentury-old barn rolls down Route 519 to new Ross Farm homeAAA Urges Caution as Deer Collision Risk Rises Across PennsylvaniaN.J. embraced AI. Flock cameras, deepfakes and Big Tech distrust have leaders wrestling with limits.Hubble Space Telescope is falling to Earth – should NASA save it?More than half of trucks inspected during North Texas operations were taken off road, agency saysThriller: Aruna risks everything to protect her baby niece from powerful men determined to kill herA drone attacked me on Salisbury Plain so I blew it to bits with a shotgun
Related Stories
Brief
Health2h ago
Satellos Changes Primary Efficacy Endpoint in BASECAMP Phase 2 Pediatric Trial to MRI-Measured Fat Fraction Following FDA Feedback
TORONTO, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a clinical-stage biotechnology company developing potentially life-improving medicines to treat degenerative muscle disorders, today announced that, following feedback from the U.S. Food and Drug Administration (FDA), it has selected change in vastus lateralis fat fraction measured by magnetic resonance imaging (MRI) as the primary efficacy endpoint in the BASECAMP Phase 2 clinical study in boys ages 7, 8 or 9 with Duchenne muscular dystrophy (DMD). Change in MRI-measured fat fraction will replace dynamometry as the study’s primary efficacy endpoint. Forazapadin is an investigational oral, small molecule designed to enhance the body’s natural ability to repair and regenerate muscle. Early clinical data in DMD have demonstrated a favorable safety and tolerability profile and encouraging signs of biological and functional activity.
GGlobe Newswire
Health2h ago
Planning To Skip Meals After Diwali To Lose Weight? Why Crash Dieting May Do More Harm Than Good
With Diwali feasts and sweets around the corner, many are planning to skip meals afterwards to shed festive kilos. But crash dieting can disrupt metabolism, digestion and hormonal balance.
TTimes Now News
Health8h ago
From cancer to diabetes: Singapore biomedical startups expand into China to accelerate development of new treatments
Singapore startups are tapping China’s vast patient pool, hospital networks and manufacturing capabilities, but they must also navigate its evolving regulatory landscape.
CChannel Newsasia